Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US
- PMID: 38129903
- PMCID: PMC10740221
- DOI: 10.1186/s12954-023-00918-3
Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US
Abstract
Background: Medications for opioid use disorder (OUD) are effective at preventing overdose and infectious disease but are vastly under-prescribed in the US. For decades, prescribers faced additional training and regulation to prescribe buprenorphine which stigmatized the medication and lessened support for a harm reduction approach to treating opioid use disorder. The Drug Enforcement Administration removed the X-waiver requirement for prescribing buprenorphine in late 2022, which removed stigma and lessened important barriers to prescribing but also left training at the discretion of individual organizations. Our study aimed to assess differences in knowledge, confidence, and stigma regarding buprenorphine between those who went through the X-waiver training and those who did not, among practicing primary care providers (PCPs).
Methods: We assessed buprenorphine prescribing readiness among primary care aligned outpatient providers in Ohio, USA. Using survey data, we conducted bivariate and regression analyses predicting primary prescribing outcomes. Primary outcomes measured knowledge of and confidence in buprenorphine, as well as perceived adequacy of one's training. Secondary outcomes were attitudes toward patients with OUD, including bias toward OUD patients, stress when working with them, and empathy toward them. Participants (n = 403) included physicians, nurse practitioners, and physician assistants practicing in primary care aligned disciplines.
Results: Survey data showed that PCPs who received X-waiver training were more likely to understand and have confidence in the mechanism of buprenorphine, and consider their training on treating OUD to be adequate. PCPs with an X-waiver showed more empathy, less negative bias, and experienced less stress when working with patients with OUD.
Conclusion: Removing restrictive policies for prescribing buprenorphine is an important step to expanding access and reducing the stigma associated with opioid use disorder treatment. Yet, our findings suggest that the training received alongside regulation may be important for improving prescribing confidence and reducing stigma. Strategies to increase buprenorphine prescribing are unlikely to be effective without also expanding access to prescribing support for primary care providers across the career course.
Keywords: Addiction medicine; Buprenorphine; Medications for opioid use disorder; Misinformation; Opioid-related disorders; Primary care.
© 2023. The Author(s).
Conflict of interest statement
None of the authors have competing interests to report.
Similar articles
-
Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver.JAMA Netw Open. 2022 May 2;5(5):e2212419. doi: 10.1001/jamanetworkopen.2022.12419. JAMA Netw Open. 2022. PMID: 35552721 Free PMC article.
-
Buprenorphine Waiver Attitudes Among Primary Care Providers.J Prim Care Community Health. 2022 Jan-Dec;13:21501319221112272. doi: 10.1177/21501319221112272. J Prim Care Community Health. 2022. PMID: 35822763 Free PMC article.
-
Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.J Am Assoc Nurse Pract. 2023 Feb 1;35(2):112-121. doi: 10.1097/JXX.0000000000000811. J Am Assoc Nurse Pract. 2023. PMID: 36512806
-
Buprenorphine X-waiver exemption - beyond the basics for the obstetrical provider.Am J Obstet Gynecol MFM. 2021 Nov;3(6):100451. doi: 10.1016/j.ajogmf.2021.100451. Epub 2021 Jul 25. Am J Obstet Gynecol MFM. 2021. PMID: 34320429 Review.
-
A practical review of buprenorphine utilization for the emergency physician in the era of decreased prescribing restrictions.Am J Emerg Med. 2021 Oct;48:316-322. doi: 10.1016/j.ajem.2021.06.065. Epub 2021 Jul 5. Am J Emerg Med. 2021. PMID: 34274576 Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical